FIELD: medicine, urology. SUBSTANCE: the method deals with treating prostatic adenoma. To determine therapy type one should study volumetric rate of urination due to uroflowmetry. Then it is necessary to prescribe the intake of α1 - adrenoblocking agent for 2 wk, for example, tamsulozine. Repeated uroflowmetry should be carried out. In case of higher value under testing after treating with α1 - adrenoblocking agent it is necessary to continue medicinal therapy, in case of deterioration - one should conduct surgical treatment. EFFECT: shortened terms and improved quality of therapy. 2 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
METHOD FOR DETERMINATION OF TREATMENT STRATEGY FOR LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA AGAINST THE BACKGROUND OF TESTOSTERONE DEFICIENCY | 2022 |
|
RU2795840C1 |
METHOD OF TREATING BENIGN HYPERPLASIA OF PROSTATE GLAND | 2012 |
|
RU2489093C1 |
METHOD FOR TREATING PATIENTS SUFFERING FROM BENIGN HYPERPLASIA OF THE PROSTATE | 2003 |
|
RU2250748C2 |
METHOD FOR TREATING THE CASES OF CHRONIC PROSTATITIS OF VARIOUS ETIOLOGY | 1999 |
|
RU2176534C2 |
METHOD FOR COMBINATION THERAPY OF BENIGN PROSTATIC HYPERPLASIA OF LARGE DIMENSIONS IN AGED PATIENTS OR PATIENTS WITH MARKED INTERCURRENT PATHOLOGY | 2015 |
|
RU2585431C1 |
AGENT FOR PREVENTING AND TREATING PROSTATITIS AND PROSTATE ADENOMA | 2013 |
|
RU2538615C1 |
METHOD OF RESORT THERAPY OF BENIGN PROSTATIC HYPERPLASIA COMPLICATED BY CHRONIC PROSTATITIS WITH DOMINANT SYMPTOM OF NOCTURIA | 2013 |
|
RU2532353C1 |
METHOD OF PREDICTING A RISK OF COMPLICATIONS OF UNIPOLAR TRANSURETHRAL ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA | 2018 |
|
RU2698623C1 |
METHOD FOR DIAGNOSING INFRAVESICAL OBSTRUCTION CASES | 2006 |
|
RU2301624C1 |
Authors
Dates
2003-05-27—Published
2001-06-05—Filed